Case report: Mafb promoter activity may define the alveolar macrophage dichotomy

Thao Vo1, Yogesh Saini1

  • 1Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, United States.

Frontiers in Immunology
|December 29, 2022
PubMed

Insights

The Mafb-Cre mouse line shows activity in approximately 40% of alveolar macrophages, offering a tool for targeted gene recombination in specific lung environments. This strain allows for conditional gene deletion in alveolar macrophages responding to Th2 stimulation.

Area of Science:

  • Immunology
  • Genetics
  • Cell Biology

Background:

  • The Cre-loxP system is crucial for conditional gene manipulation.
  • Existing macrophage promoter-specific Cre recombinase mouse strains have limitations.
  • The Mafb-Cre mouse strain labels macrophages across various organs, but its efficacy in alveolar macrophages was untested.

Observation:

  • Mafb-Cre activity was assessed in alveolar macrophages using a reporter system (mTOM/mEGFP).
  • Approximately 40% of alveolar macrophages showed Mafb-Cre activity, independent of age.
  • Mafb-Cre+ alveolar macrophages exhibited elevated MHCII surface expression compared to Mafb-Cre- cells.

Findings:

  • Bone marrow-derived macrophages from Mafb mice are amenable to in vitro Cre-LoxP recombination.
  • Chimeric mouse experiments indicated high Mafb-Cre recombination potential in alveolar macrophages (~98%).
  • Th2 stimulation and ozone exposure enhanced Mafb-Cre recombination in alveolar macrophages.

Implications:

  • The Mafb-Cre strain allows for targeted gene deletion in a subset of alveolar macrophages.
  • This tool is valuable for studying gene function in alveolar macrophages within specific lung microenvironments, particularly those associated with Th2 responses.
  • The heterogeneity in Mafb-Cre activity within the alveolar macrophage population limits its use for targeting the entire population but enables specific subset analysis.